TFAM and Platelet storage pool disease: However, AntiOxCIN4 treatment increased Tfam mRNA levels in both fibroblasts from sPD patients and in their sex- and age-matched controls (Fig. 5D), while TFB2m mRNA levels was increased only in fibroblasts from sPD patients (Fig. 5E).